Rezolute Inc (RZLT) gains 0.48% for July 21

Equities Staff  |

Rezolute Inc (NASDAQ: RZLT) shares gained 0.48%, or $0.0507 per share, to close Wednesday at $10.65. After opening the day at $10.38, shares of Rezolute fluctuated between $10.86 and $10.50. 9,143 shares traded hands a decrease from their 30 day average of 38,503. Wednesday's activity brought Rezolute’s market cap to $88,951,750.

Rezolute is headquartered in Redwood City, California..

About Rezolute Inc

Rezolute is advancing targeted therapies for rare, metabolic, and life-threatening diseases. Its lead clinical asset, RZ358, is in Phase 2b development as a potential treatment for CHI, a rare pediatric endocrine disorder. Its pipeline also includes RZ402, an IND-ready orally available plasma kallikrein inhibitor, which is staged to transition into clinical development for the treatment of diabetic macular edema.

Visit Rezolute Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Rezolute Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Rezolute Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content